Protalix Biotherapeutics Inc
AMEX:PLX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Protalix Biotherapeutics Inc
AMEX:PLX
|
US |
|
E
|
Evolus Inc
F:EVL
|
US |
|
Koninklijke Ahold Delhaize NV
OTC:AHODF
|
NL |
|
S
|
Samart Corporation PCL
SET:SAMART
|
TH |
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
JP |
|
I
|
Intercontinental Exchange Inc
F:IC2
|
US |
|
C
|
Cadence Design Systems Inc
XMUN:CDS
|
US |
|
Arverne Group SA
F:5H1
|
FR |
|
I
|
Interlink Telecom PCL
SET:ITEL
|
TH |
|
U
|
Uniqa Insurance Group AG
SWB:UN9
|
AT |
|
Murata Manufacturing Co Ltd
TSE:6981
|
JP |
|
S
|
SanDisk Corp
XHAM:BW9
|
US |
|
AUTO1 Group SE
OTC:ATOGY
|
DE |
|
TradeDoubler AB
F:T1D
|
SE |
|
S
|
SanDisk Corp
DUS:BW9
|
US |
Wall St Price Targets
PLX Price Targets Summary
Protalix Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for PLX is 11.22 USD with a low forecast of 10.1 USD and a high forecast of 12.6 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PLX's stock price target?
Price Target
11.22
USD
According to Wall Street analysts, the average 1-year price target for PLX is 11.22 USD with a low forecast of 10.1 USD and a high forecast of 12.6 USD.
What is the Revenue forecast for Protalix Biotherapeutics Inc?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 3 years is 9%.
What is the Gross Profit forecast for Protalix Biotherapeutics Inc?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 23%. The projected CAGR for the next 6 years is 7%.
